April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

Mustang raises $27.5M after gene therapy data

Mustang Bio Inc. (NASDAQ:MBIO) raised $27.5 million in a follow-on underwritten by Cantor Fitzgerald, Oppenheimer, H.C. Wainwright and Roth Capital. The offering comes on the heels of positive data from Mustang and St. Jude for a gene therapy to treat X-linked severe combined immunodeficiency (see "St. Jude, Mustang Gene Therapy Produces Functional Immunity in SCID-X1 Patients")...